Unaudited Condensed Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Convertible Preferred Stock [Member]	Series A Convertible Preferred Stock [Member]	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Temporary equity, Beginning balance at Dec. 31, 2020		$ 21,624
Temporary equity, Beginning balance (in shares) at Dec. 31, 2020		6,838,829
Beginning balance at Dec. 31, 2020	$ (14,638)				$ 1	$ 100		$ (14,739)
Beginning balance (in shares) at Dec. 31, 2020					1,046,599
Issuance of convertible preferred stock, net of issuance costs			$ 55,722	$ 124,825
Issuance of convertible preferred stock, net of issuance costs (in shares)			5,894,740	8,038,073
Conversion of convertible preferred stock in connection with initial public offering, converted	202,171	$ (202,171)
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted (in shares)		(20,771,642)
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued	202,171				$ 27	202,144
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued (in shares)					26,608,460
Initial public offering, net of issuance costs	204,137				$ 13	204,124
Initial public offering, net of issuance costs (in shares)					13,110,000
Exercise of common stock options	20					20
Exercise of common stock options (in shares)					113,418
Vesting of restricted shares	178					178
Vesting of restricted shares (in shares)					216,082
Stock-based compensation	1,400					1,400
Unrealized gain (loss) on available-for-sale securities, net	17						$ 17
Net loss	(8,490)							(8,490)
Ending balance at Jun. 30, 2021	384,795				$ 41	407,966	17	(23,229)
Ending balance (in shares) at Jun. 30, 2021					41,094,559
Temporary equity, Beginning balance at Mar. 31, 2021		$ 77,346
Temporary equity, Beginning balance (in shares) at Mar. 31, 2021		12,733,569
Beginning balance at Mar. 31, 2021	(16,771)				$ 1	251		(17,023)
Beginning balance (in shares) at Mar. 31, 2021					1,226,977
Issuance of convertible preferred stock, net of issuance costs				$ 124,825
Issuance of convertible preferred stock, net of issuance costs (in shares)				8,038,073
Conversion of convertible preferred stock in connection with initial public offering, converted		$ (202,171)
Conversion of convertible preferred stock to common stock in connection with initial public offering, converted (in shares)		(20,771,642)
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued	202,171				$ 27	202,144
Conversion of convertible preferred stock to common stock in connection with initial public offering, issued (in shares)					26,608,460
Initial public offering, net of issuance costs	204,137				$ 13	204,124
Initial public offering, net of issuance costs (in shares)					13,110,000
Vesting of restricted shares	170					170
Vesting of restricted shares (in shares)					149,122
Stock-based compensation	1,277					1,277
Unrealized gain (loss) on available-for-sale securities, net	17						17
Net loss	(6,206)							(6,206)
Ending balance at Jun. 30, 2021	384,795				$ 41	407,966	17	(23,229)
Ending balance (in shares) at Jun. 30, 2021					41,094,559
Beginning balance at Dec. 31, 2021	366,327				$ 41	413,967	(270)	(47,411)
Beginning balance (in shares) at Dec. 31, 2021					41,243,137
Conversion of convertible preferred stock in connection with initial public offering, converted	0
Exercise of common stock options	$ 1					1
Exercise of common stock options (in shares)	7,405				7,405
Shares issued under employee stock purchase plan	$ 307					307
Shares issued under employee stock purchase plan (in shares)					32,662
Vesting of restricted shares	712				$ 1	711
Vesting of restricted shares (in shares)					218,065
Stock-based compensation	8,402					8,402
Unrealized gain (loss) on available-for-sale securities, net	(1,637)						(1,637)
Net loss	(30,298)							(30,298)
Ending balance at Jun. 30, 2022	343,814				$ 42	423,388	(1,907)	(77,709)
Ending balance (in shares) at Jun. 30, 2022					41,501,269
Beginning balance at Mar. 31, 2022	356,082				$ 41	418,429	(1,567)	(60,821)
Beginning balance (in shares) at Mar. 31, 2022					41,393,660
Exercise of common stock options (in shares)					1,000
Shares issued under employee stock purchase plan	307					307
Shares issued under employee stock purchase plan (in shares)					32,662
Vesting of restricted shares	209				$ 1	208
Vesting of restricted shares (in shares)					73,947
Stock-based compensation	4,444					4,444
Unrealized gain (loss) on available-for-sale securities, net	(340)						(340)
Net loss	(16,888)							(16,888)
Ending balance at Jun. 30, 2022	$ 343,814				$ 42	$ 423,388	$ (1,907)	$ (77,709)
Ending balance (in shares) at Jun. 30, 2022					41,501,269